Phase 2 Head and Neck Cancer Trial, Recruiting NCT06353685 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Phase 2 Head and Neck Cancer Trial, Recruiting

NCT06353685
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with oral cavity cancer (confirmed by tissue testing) that has not yet been treated, at a stage of T2-4N0M0 or T1-4N1-3M0 (stages II to IVB based on a standard cancer staging system)
  • People whose surgical tissue showed either no remaining cancer cells (complete response) or very few remaining cancer cells — 10% or less (major response) — after pre-surgery treatment
  • People whose surgery removed all cancer with clear edges, meaning no cancer cells were found at the borders of what was removed
  • People whose cancer had not spread beyond the lymph nodes into surrounding tissue
  • People aged 18 to 80 years old
  • People who are generally well enough to carry out daily activities, with minimal or no limitations (as measured by a standard health performance scale scoring 0 or 1)
  • People with a life expectancy of more than 6 months
  • Women who are able to become pregnant and agree to use contraception during treatment and for 3 months after treatment ends
  • People whose pre-surgery treatment plan was decided by their treating doctor
  • People who are willing to participate voluntarily and have signed a consent form

Who may not be able to join:

  • Women who are pregnant or breastfeeding
  • People who have had another cancer diagnosis in the past 5 years, except for certain fully treated cancers including a specific type of skin cancer (basal cell carcinoma), early-stage cervical cancer, or thyroid papilloma
  • People who did not complete their pre-surgery treatment or their surgery
  • People whose cancer came back or spread to other parts of the body before post-surgery radiation treatment began
  • People who have medical reasons that prevent them from receiving radiation, chemotherapy, immunotherapy, or targeted therapy
  • People with heart conditions or heart disease that is not well controlled
  • People with serious active infections
  • People with a history of immune system deficiency, including HIV, other immune conditions present from birth or developed later, or a history of organ or bone marrow transplant
  • People with active tuberculosis (TB), a TB infection within the past year, or a TB infection at any time that was not properly treated
  • People with active hepatitis B or hepatitis C infections above certain measurable levels in the blood
  • People with a known history of substance abuse, heavy alcohol use, or drug use
  • People the trial investigators consider unsuitable for participation for other medical reasons (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 13632301621

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Registry
ClinicalTrials.gov
Start date
1 May 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

2-year PFS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov